Veradermics MANE Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Veradermics in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Veradermics ’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Veradermics 's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Veradermics 's total equity?
- Veradermics (MANE) reported total equity of $390.64M in Q1 2026.
- How has Veradermics 's total equity changed year-over-year?
- Veradermics 's total equity increased by 743.9% year-over-year, from -$60.67M to $390.64M.
- What is the long-term trend for Veradermics 's total equity?
- Over 2 years (2023 to 2025), Veradermics 's total equity has grown at a 133.3% compound annual growth rate (CAGR), from -$22.24M to -$121.01M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.